Let's catch up on the latest news from the stock market. From significant investments to major deals, quarterly earnings, and ...

AstraZeneca's (NASDAQ:AZN) selloff on Tuesday in response to reports that the company is facing a fraud investigation in ...

Kroger did not admit to wrongdoing in the settlement, but it did agree to pay nearly $1.4 billion over the coming 11 years to ...

AstraZeneca’s stock price dropped by 8.4% during Tuesday’s trading in London after a report fueled fears of a potentially ...

Arcellx has shared several data cuts on anito-cel, a CAR-T being developed with Gilead’s Kite Pharma to treat relapsed or ...

On Monday, Royalty Pharma plc (RPRX) stock saw a modest uptick, ending the day at $27.2 which represents a slight increase of $0.10 or 0.37% from the prior close of $27.1. The stock opened at $27.52 ...

Sanofi has released phase 3 data from the LUNA 3 trial of rilzabrutinib that should spark some buyer’s delight. | Sanofi has released phase 3 data from the LUNA 3 trial of rilzabrutinib that should ...

A South Florida company aims to grow its presence in Europe as more countries reconsider their policies on cannabis.

The US FDA has approved Vyloy in combination with fluoropyrimidine- and platinum-containing chemotherapy for the first-line treatment of advanced gastric or gastroesophageal junction cancer.

Mexican-American Pablo Legorreta founded Royalty Pharma, which provides funding to pharmaceutical developers in exchange for ...

Mankind Pharma on Tuesday reported a 29 per cent rise in its consolidated net profit to Rs 658.88 crore for the second ...

Both Harris and Trump made closing arguments to voters across swing states over the weekend and Monday. Each promised vastly ...